Correspondence 0001558370-24-006565 from Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc.
Date: May 2, 2024 · CIK: 0001840233 · Accession: 0001558370-24-006565
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279015
Letter
May 2, 2024
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Tim Buchmiller
Re: Xilio Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 30, 2024
File No. 333-279015
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Xilio Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-279015), so that it may become effective at 4:00 p.m. Eastern time on May 6, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission.
Very truly yours,
XILIO THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm May 2, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Tim Buchmiller Re: Xilio Therapeutics, Inc. Registration Statement on Form S-3 Filed April 30, 2024 File No. 333-279015 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Xilio Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-279015), so that it may become effective at 4:00 p.m. Eastern time on May 6, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission. Very truly yours, XILIO THERAPEUTICS, INC. By:/s/ René Russo René Russo President and Chief Executive Officer